ENDO HEALTH SOLUTIONS INC. Research and Development Expense
ENDO HEALTH SOLUTIONS INC. reported Research and Development Expense of $142.47 million for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2014-03-03
- ENDO HEALTH SOLUTIONS INC. research and development expense for the quarter ending 2013-12-31 was $28.73M, a 20.35% decline year-over-year.
- ENDO HEALTH SOLUTIONS INC. research and development expense for the quarter ending 2013-09-30 was $38.08M, a 22.21% decline year-over-year.
- ENDO HEALTH SOLUTIONS INC. research and development expense for the quarter ending 2013-06-30 was $34.09M, a 24.95% decline year-over-year.
- ENDO HEALTH SOLUTIONS INC. research and development expense for the quarter ending 2013-03-31 was $41.57M, a 53.13% decline year-over-year.
- ENDO HEALTH SOLUTIONS INC. research and development expense for fiscal 2013 was $142.47M, a 34.99% decline from fiscal 2012.
- ENDO HEALTH SOLUTIONS INC. research and development expense for fiscal 2012 was $219.14M, a 21.85% increase from fiscal 2011.
- ENDO HEALTH SOLUTIONS INC. research and development expense for fiscal 2011 was $179.84M, a 24.43% increase from fiscal 2010.
- ENDO HEALTH SOLUTIONS INC. research and development expense for fiscal 2010 was $144.53M, a 22.01% decline from fiscal 2009.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2013-12-31 | $28.73M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $66.81M derived: sum of 2 quarters · filed 2014-03-03 | $100.90M derived: sum of 3 quarters · filed 2014-03-03 | $142.47M 10-K · filed 2014-03-03 | |
| 2013-09-30 | $38.08M 10-Q · filed 2013-11-05 | $72.17M derived: sum of 2 quarters · filed 2013-11-05 | $113.74M 10-Q · filed 2013-11-05 | $149.81M derived: sum of 4 quarters · filed 2014-03-03 | |
| 2013-06-30 | $34.09M 10-Q · filed 2013-08-06 | $75.66M 10-Q · filed 2013-08-06 | $111.73M derived: sum of 3 quarters · filed 2014-03-03 | $160.68M derived: sum of 4 quarters · filed 2014-03-03 | |
| 2013-03-31 | $41.57M 10-Q · filed 2013-05-07 | $77.64M derived: sum of 2 quarters · filed 2014-03-03 | $126.59M derived: sum of 3 quarters · filed 2014-03-03 | $172.02M derived: sum of 4 quarters · filed 2014-03-03 | |
| 2012-12-31 | $36.07M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $85.02M derived: sum of 2 quarters · filed 2014-03-03 | $130.45M derived: sum of 3 quarters · filed 2014-03-03 | $219.14M 10-K · filed 2014-03-03 | $226.12M 10-K · filed 2013-03-01 |
| 2012-09-30 | $48.95M 10-Q · filed 2013-11-05 | $94.38M derived: sum of 2 quarters · filed 2013-11-05 | $183.07M 10-Q · filed 2013-11-05 | $236.05M derived: sum of 4 quarters · filed 2014-03-03 | |
| 2012-06-30 | $45.43M 10-Q · filed 2013-08-06 | $134.12M 10-Q · filed 2013-08-06 | $187.10M derived: sum of 3 quarters · filed 2014-03-03 | $230.98M derived: sum of 4 quarters · filed 2014-03-03 | |
| 2012-03-31 | $88.69M 10-Q · filed 2013-05-07 | $141.67M derived: sum of 2 quarters · filed 2014-03-03 | $185.56M derived: sum of 3 quarters · filed 2014-03-03 | $226.40M derived: sum of 4 quarters · filed 2014-03-03 | |
| 2011-12-31 | $52.98M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $96.87M derived: sum of 2 quarters · filed 2014-03-03 | $137.71M derived: sum of 3 quarters · filed 2014-03-03 | $179.84M 10-K · filed 2014-03-03 | $182.29M 10-K · filed 2012-02-29 |
| 2011-09-30 | $43.88M 10-Q · filed 2012-11-05 | $84.72M derived: sum of 2 quarters · filed 2012-11-05 | $126.85M 10-Q · filed 2012-11-05 | $166.11M derived: sum of 4 quarters · filed 2012-11-05 | |
| 2011-06-30 | $40.84M 10-Q · filed 2012-08-07 | $82.97M 10-Q · filed 2012-08-07 | $122.23M derived: sum of 3 quarters · filed 2012-08-07 | $153.67M derived: sum of 4 quarters · filed 2012-08-07 | |
| 2011-03-31 | $42.13M 10-Q · filed 2012-05-01 | $81.39M derived: sum of 2 quarters · filed 2012-05-01 | $112.83M derived: sum of 3 quarters · filed 2012-05-01 | $157.49M derived: sum of 4 quarters · filed 2012-05-01 | |
| 2010-12-31 | $39.26M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | $70.70M derived: sum of 2 quarters · filed 2012-02-29 | $115.36M derived: sum of 3 quarters · filed 2012-02-29 | $144.53M 10-K · filed 2012-02-29 | |
| 2010-09-30 | $31.45M 10-Q · filed 2011-10-31 | $76.10M derived: sum of 2 quarters · filed 2011-10-31 | $105.27M 10-Q · filed 2011-10-31 | $153.97M derived: sum of 4 quarters · filed 2012-02-29 | |
| 2010-06-30 | $44.66M 8-K · filed 2011-10-14 | $73.82M 8-K · filed 2011-10-14 | $122.53M derived: sum of 3 quarters · filed 2012-02-29 | $182.22M derived: sum of 4 quarters · filed 2012-02-29 | |
| 2010-03-31 | $29.17M 10-Q · filed 2011-04-29 | $77.87M derived: sum of 2 quarters · filed 2012-02-29 | $137.56M derived: sum of 3 quarters · filed 2012-02-29 | $186.07M derived: sum of 4 quarters · filed 2012-02-29 | |
| 2009-12-31 | $48.70M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | $108.39M derived: sum of 2 quarters · filed 2012-02-29 | $156.90M derived: sum of 3 quarters · filed 2012-02-29 | $185.32M 10-K · filed 2012-02-29 | |
| 2009-09-30 | $59.69M 10-Q · filed 2010-11-02 | $108.20M derived: sum of 2 quarters · filed 2010-11-02 | $136.61M 10-Q · filed 2010-11-02 | ||
| 2009-06-30 | $48.51M 10-Q · filed 2010-08-02 | $76.92M 10-Q · filed 2010-08-02 | |||
| 2008-12-31 | $110.21M 8-K · filed 2011-10-14 |